Dr. Paul M. Barr
Claim this profileUniversity of Rochester
About Paul M. Barr
Education:
- Earned an MD from Northeast Ohio Medical University in 2000.
Experience:
- Completed internship, residency, and chief residency at Case Western Reserve University.
- Fellowship in Hematology and Oncology at Case Western.
- Holds subspecialty certification in Hematology and Oncology.
- Serves as an Associate Professor of Medicine at the University of Rochester.
- Director of the Clinical Trials Office for the Wilmot Cancer Institute.
Area of expertise
Lung Cancer
Paul M. Barr has run 12 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Paul M. Barr has run 10 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Rochester
Wilmot Cancer Institute At Webster
Clinical Trials Paul M. Barr is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
More about Paul M. Barr
Clinical Trial Related
7 years of experience running clinical trials · Led 85 trials as a Principal Investigator · 34 Active Clinical Trials
Treatments Paul M. Barr has experience with
- Nivolumab
- Cisplatin
- Pembrolizumab
- Carboplatin
- Cytarabine
- Cyclophosphamide
Breakdown of trials Paul M. Barr has run
Lung Cancer
Breast Cancer
Breast cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul M. Barr specialize in?
Paul M. Barr focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul M. Barr currently recruiting for clinical trials?
Yes, Paul M. Barr is currently recruiting for 34 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Paul M. Barr has studied deeply?
Yes, Paul M. Barr has studied treatments such as Nivolumab, Cisplatin, Pembrolizumab.
What is the best way to schedule an appointment with Paul M. Barr?
Apply for one of the trials that Paul M. Barr is conducting.
What is the office address of Paul M. Barr?
The office of Paul M. Barr is located at: University of Rochester, Rochester, New York 14642 United States. This is the address for their practice at the University of Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.